Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
- 1 October 1992
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 103 (4) , 1267-1272
- https://doi.org/10.1016/0016-5085(92)91514-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosisHepatology, 1990
- More on ascitic fluid culture techniqueHepatology, 1989
- Endoscopic Hemostasis by Local Injection of Epinephrine and Polidocanol in Bleeding Ulcer. A Prospective Randomized TrialEndoscopy, 1988
- Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitisJournal of Hepatology, 1988
- Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factorsHepatology, 1988
- Effect of Norfloxacin on Human Oropharyngeal and Colonic Microflora and Multiple-dose PharmacokineticsScandinavian Journal of Infectious Diseases, 1987
- Norfloxacin A Review of Its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic UseDrugs, 1985
- Cefotaxime Is More Effective Than Is Ampicillin–Tobramycin in Cirrhotics With Severe InfectionsHepatology, 1985
- Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver diseaseHepatology, 1981
- Biosynthesis of Intestinal Mucin in ShockAnnals of Surgery, 1966